Cart
0

Vascular Graft Market by Product (Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Graft, and Peripheral Vascular Graft), by Raw Material (Polyester, Polytetrafluoroethylene (PTFE), Polyurethane, and Biosynthetic), and by End-User (Hospitals and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_172435
Pages: 150
Aug 2017 | 3317 Views
 
Author's : Amrita Srivastava & Pallavi Jaiswal
Tables: 50
Charts: 86
 

Vascular Graft Market Overview:

Global Vascular Graft Market was valued at $4,192 million in 2016, and is expected to reach $6,218 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023. A vascular graft is a medical device that acts as an artificial blood vessel. They are implanted in the patients with blocked blood vessels to redirect the flow of blood from one area to another. This restores normal flow of blood within the body.

Rise in incidence of vascular disorders, high blood sugar, hypertension, and other risk factors that lead to blockage of blood vessels drive the growth of the vascular grafts market. In addition, increase in geriatric population, technological advancements, and changes in life style (consumption of junk food, tobacco, and alcohol) are also expected to boost the market growth. However, high cost of treatment, and complications associated with prosthetic grafts restrain growth. Increase in awareness for vascular grafts and growth prospects in emerging economies of Asia-Pacific and LAMEA provide numerous growth opportunities during the forecast period.

Segment Review

Endovascular aneurysm repair stent grafts was the major segment in 2016 and is expected to remain so throughout the forecast period. With the evolution of endovascular aneurysm repair, aneurysm treatment has become much more convenient for the patients as they form a minimally invasive alternative to open surgeries. In this regard, Medtronic developed Endurant II AAA Stent Graft System to treat AAA. This system is placed into the abdominal aneurysm to provide an alternative channel for the flow of blood. Medtronic also developed Valiant Thoracic Stent Graft to treat TAA. This device has shown exceptional performance in the treatment of thoracic aneurysms and has healed more than 65,000 patients across the globe.

Snapshot of LAMEA Vascular Graft Market

Surge in incidence of vascular disorders, end stage renal disease, and diabetes coupled with rapid growth in geriatric population drives the growth of the vascular grafts market in LAMEA. Moreover, increase in focus of the key players in this region and growth in healthcare expenditure per capita is expected to boost the market growth in LAMEA.

Saudi Arabia Vascular Graft Market, 2016-2023 ($Million)

Saudi Arabia Vascular Graft Market, 20162023 ($Million)

Get more information on this report : Request Sample Pages

The list of key players profiled in this report include B. Braun Melsungen AG, C. R. Bard, Inc., Cardinal Health Inc., Cook Medical Inc., Endologix Inc., LeMaitre Vascular, Inc., MAQUET Holding B.V. & Co. KG, Medtronic plc, Terumo Corporation, and W. L. Gore & Associates, Inc.

Other key players in the value chain include Cardiatis S.A., Jotec GmbH, Lombard Medical, Inc., and Nano Endoluminal.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Product and raw material segmentation analysis helps understand various types of devices and materials used to manufacture vascular grafts.
  • Comprehensive analysis of all regions determines the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global market.

Vascular Graft Market Key Segments:

By Product

  • Hemodialysis Access Graft
  • Endovascular Aneurysm Repair Stent Grafts
    • Abdominal Aortic Aneurysm (AAA)
    • Thoracic Aortic Aneurysm (TAA)
  • Peripheral vascular graft

By Raw Material

  • Polytetrafluoroethylene (PTFE)
  • Polyurethane (PU)
  • Polyester
  • Biosynthetic

By End User

  • Hospitals
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence and strategies of companies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increase in prevalence of risk factors that lead to blockage of blood vessels
3.4.1.2. Increase in sedentary lifestyle and rise in geriatric population
3.4.1.3. Technological advancements
3.4.1.4. Improvement in healthcare infrastructure in developing countries

3.4.2. Restraints

3.4.2.1. High cost of treatment
3.4.2.2. Complications associated with the prosthetic grafts

3.4.3. Opportunities

3.4.3.1. Increase in patient awareness
3.4.3.2. Huge market opportunities in developing nations

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

Chapter: 4 VASCULAR GRAFTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. HEMODIALYSIS ACCESS GRAFTS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Abdominal aortic aneurysm

4.3.4.1. Market size and forecast

4.3.5. Thoracic aortic aneurysm

4.3.5.1. Market size and forecast

4.4. PERIPHERAL VASCULAR GRAFT

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 VASCULAR GRAFTS MARKET, BY RAW MATERIAL

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. POLYESTER

5.2.1. Market size and forecast

5.3. POLYTETRAFLUOROETHYLENE (PTFE)

5.3.1. Market size and forecast

5.4. POLYURETHANE

5.4.1. Market size and forecast

5.5. BIOSYNTHETIC

5.5.1. Market size and forecast

Chapter: 6 VASCULAR GRAFTS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS (ASCS)

6.3.1. Market size and forecast

Chapter: 7 VASCULAR GRAFTS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Italy
7.3.8. Spain
7.3.9. Rest of Europe

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan
7.4.5. China
7.4.6. India
7.4.7. South Korea
7.4.8. Australia
7.4.9. Rest of Asia-Pacific

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. South Africa
7.5.6. Saudi Arabia
7.5.7. Rest of LAMEA

Chapter: 8 COMPANY PROFILES

8.1. B. BRAUN MELSUNGEN AG

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance

8.2. C. R. BARD INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. CARDINAL HEALTH, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. COOK MEDICAL

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments

8.5. ENDOLOGIX INC.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. GETINGE GROUP

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. LEMAITRE VASCULAR, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. MEDTRONIC PLC

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. TERUMO MEDICAL CORPORATION

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. W. L. GORE & ASSOCIATES, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. VASCULAR GRAFTS MARKET FOR HEMODIALYSIS ACCESS GRAFTS, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL VASCULAR GRAFTS MARKET FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY TYPE, 2016-2023 ($MILLION)
TABLE 4. VASCULAR GRAFTS MARKET FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. VASCULAR GRAFTS MARKET FOR PERIPHERAL VASCULAR GRAFT, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 7. VASCULAR GRAFTS MARKET FOR POLYESTER, BY REGION, 2016-2023 ($MILLION)
TABLE 8. VASCULAR GRAFTS MARKET FOR POLYTETRAFLUOROETHYLENE (PTFE), BY REGION, 2016-2023 ($MILLION)
TABLE 9. VASCULAR GRAFTS MARKET FOR POLYURETHANE, BY REGION, 2016-2023 ($MILLION)
TABLE 10. VASCULAR GRAFTS MARKET FOR BIOSYNTHETIC, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 12. VASCULAR GRAFTS MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. VASCULAR GRAFTS MARKET FOR ASCS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. VASCULAR GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA VASCULAR GRAFTS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. EUROPE VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. EUROPE VASCULAR GRAFTS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 21. EUROPE VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 22. EUROPE VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 23. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 25. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. LAMEA VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. LAMEA VASCULAR GRAFTS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 29. LAMEA VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 30. LAMEA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. B BRAUN: COMPANY SNAPSHOT
TABLE 32. B BRAUN: OPERATING SEGMENTS
TABLE 33. B BRAUN: PRODUCT PORTFOLIO
TABLE 34. C. R. BARD MEDICAL: COMPANY SNAPSHOT
TABLE 35. C. R. BARD: OPERATING SEGMENTS
TABLE 36. C. R. BARD: PRODUCT PORTFOLIO
TABLE 37. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 38. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 39. CORDIS: PRODUCT PORTFOLIO
TABLE 40. COOK: COMPANY SNAPSHOT
TABLE 41. COOK: OPERATING SEGMENTS
TABLE 42. COOK: PRODUCT PORTFOLIO
TABLE 43. ENDOLOGIX: COMPANY SNAPSHOT
TABLE 44. ENDOLOGIX: OPERATING SEGMENTS
TABLE 45. ENDOLOGIX: PRODUCT PORTFOLIO
TABLE 46. GETINGE: COMPANY SNAPSHOT
TABLE 47. GETINGE: OPERATING SEGMENTS
TABLE 48. MAQUET: PRODUCT PORTFOLIO
TABLE 49. LEMAITRE VASCULAR: COMPANY SNAPSHOT
TABLE 50. LEMAITRE VASCULAR: OPERATING SEGMENTS
TABLE 51. LEMAITRE VASCULAR: PRODUCT PORTFOLIO
TABLE 52. MEDTRONIC: COMPANY SNAPSHOT
TABLE 53. MEDTRONIC: OPERATING SEGMENTS
TABLE 54. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 55. TERUMO: COMPANY SNAPSHOT
TABLE 56. TERUMO: OPERATING SEGMENTS
TABLE 57. TERUMO: PRODUCT PORTFOLIO
TABLE 58. GORE: COMPANY SNAPSHOT
TABLE 59. GORE: OPERATING SEGMENTS
TABLE 60. GORE: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. VASCULAR GRAFTS MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES, 20172023 (%)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES (COMPANY AND NATURE OF STRATEGY)
FIGURE 7. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES (COMPANY AND TYPE OF STRATEGY)
FIGURE 8. MARKET SHARE ANALYSIS, 2016
FIGURE 9. PREVALENCE OF PERIPHERAL ARTERY DISEASE (%), BY AGE GROUP (YEARS)
FIGURE 10. PREVALENCE OF HIGH BLOOD PRESSURE IN ADULTS, (%), 2009-2012
FIGURE 11. IMPACT ANALYSIS: VASCULAR GRAFTS MARKET
FIGURE 12. TOTAL NUMBER OF CLINICAL TRIALS IN VASCULAR GRAFTS MARKET
FIGURE 13. TOTAL NUMBER OF CLINICAL TRIALS FOR VASCULAR GRAFTS IN NORTH AMERICA
FIGURE 14. GLOBAL VASCULAR GRAFTS MARKET, BY TYPE ($MILLION)
FIGURE 15. GLOBAL VASCULAR GRAFTS MARKET FOR HEMODIALYSIS ACCESS GRAFTS, 2016-2023 ($MILLION)
FIGURE 16. VASCULAR GRAFTS MARKET FOR HEMODIALYSIS ACCESS GRAFTS, BY REGION ($MILLION)
FIGURE 17. GLOBAL VASCULAR GRAFTS MARKET FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY TYPE ($MILLION)
FIGURE 18. VASCULAR GRAFTS MARKET FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY REGION ($MILLION)
FIGURE 19. GLOBAL VASCULAR GRAFTS MARKET FOR ABDOMINAL AORTIC ANEURYSM, 2016-2023 ($MILLION)
FIGURE 20. GLOBAL VASCULAR GRAFTS MARKET FOR THORACIC AORTIC ANEURYSM, 2016-2023 ($MILLION)
FIGURE 21. GLOBAL VASCULAR GRAFTS MARKET FOR PERIPHERAL VASCULAR GRAFT, BY TYPE, 2016-2023 ($MILLION)
FIGURE 22. VASCULAR GRAFTS MARKET FOR PERIPHERAL VASCULAR GRAFT, BY REGION ($MILLION)
FIGURE 23. GLOBAL VASCULAR GRAFTS MARKET, BY RAW MATERIAL ($MILLION)
FIGURE 24. VASCULAR GRAFTS MARKET FOR POLYESTER, BY REGION ($MILLION)
FIGURE 25. VASCULAR GRAFTS MARKET FOR POLYTETRAFLUOROETHYLENE (PTFE), BY REGION ($MILLION)
FIGURE 26. VASCULAR GRAFTS MARKET FOR POLYURETHANE, BY REGION ($MILLION)
FIGURE 27. VASCULAR GRAFTS MARKET FOR BIOSYNTHETIC, BY REGION ($MILLION)
FIGURE 28. GLOBAL VASCULAR GRAFTS MARKET, BY END USER ($MILLION)
FIGURE 29. VASCULAR GRAFTS MARKET FOR HOSPITALS, BY REGION ($MILLION)
FIGURE 30. VASCULAR GRAFTS MARKET FOR ASCS, BY REGION ($MILLION)
FIGURE 31. VASCULAR GRAFTS MARKET, BY REGION ($MILLION)
FIGURE 32. NORTH AMERICA VASCULAR GRAFTS MARKET, BY COUNTRY ($MILLION)
FIGURE 33. NORTH AMERICA VASCULAR GRAFTS MARKET, BY PRODUCT ($MILLION)
FIGURE 34. NORTH AMERICA VASCULAR GRAFTS MARKET, BY RAW MATERIAL ($MILLION)
FIGURE 35. NORTH AMERICA VASCULAR GRAFTS MARKET, BY END USER ($MILLION)
FIGURE 36. U.S. VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 37. CANADA VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 38. MEXICO VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 39. EUROPE VASCULAR GRAFTS MARKET, BY COUNTRY ($MILLION)
FIGURE 40. EUROPE VASCULAR GRAFTS MARKET, BY PRODUCT ($MILLION)
FIGURE 41. EUROPE VASCULAR GRAFTS MARKET, BY RAW MATERIAL ($MILLION)
FIGURE 42. EUROPE VASCULAR GRAFTS MARKET, BY END USER ($MILLION)
FIGURE 43. GERMANY VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 44. FRANCE VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 45. UK VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 46. ITALY VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 47. SPAIN VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 48. REST OF EUROPE VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 49. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY COUNTRY ($MILLION)
FIGURE 50. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY PRODUCT ($MILLION)
FIGURE 51. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY RAW MATERIAL ($MILLION)
FIGURE 52. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY END USER ($MILLION)
FIGURE 53. JAPAN VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 54. CHINA VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 55. INDIA VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 56. SOUTH KOREA VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 57. AUSTRALIA VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 58. REST OF ASIA-PACIFIC VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 59. LAMEA VASCULAR GRAFTS MARKET, BY PRODUCT ($MILLION)
FIGURE 60. LAMEA VASCULAR GRAFTS MARKET, BY RAW MATERIAL ($MILLION)
FIGURE 61. LAMEA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
FIGURE 62. BRAZIL VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 63. SOUTH AFRICA VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 64. SAUDI ARABIA VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 65. REST OF LAMEA VASCULAR GRAFTS MARKET ($MILLION), 2016-2023
FIGURE 66. B BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 67. B BRAUN: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 68. B BRAUN: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 69. C. R. BARD: NET SALES, 2014-2016 ($MILLION)
FIGURE 70. C. R. BARD: REVENUE BY SEGEMENTS, 2016 (%)
FIGURE 71. C. R. BARD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 72. CARDINAL HEALTH: NET SALES, 2014-2016 ($MILLION)
FIGURE 73. CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 74. ENDOLOGIX: NET SALES, 2014-2016 ($MILLION)
FIGURE 75. ENDOLOGIX: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 76. GETINGE: NET SALES, 2014-2016 ($MILLION)
FIGURE 77. GETINGE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 78. GETINGE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 79. LEMAITRE VASCULAR: NET SALES, 2014-2016 ($MILLION)
FIGURE 80. LEMAITRE VASCULAR: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 81. MEDTRONIC: NET SALES, 20152017 ($MILLION)
FIGURE 82. MEDTRONIC: REVENUE BY SEGMENTS, 2017 (%)
FIGURE 83. MEDTRONIC: REVENUE BY GEOGRAPHY, 2017 (%)
FIGURE 84. TERUMO: NET SALES, 2014-2016 ($MILLION)
FIGURE 85. TERUMO: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 86. TERUMO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Vascular Graft Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $4176 $3759
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640 $4176
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540 $4709
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654 $5324
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280 $6960
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo